Herpesvirus saimiri ( HVS ) is capable of establishing a persistent infection in a variety of human carcinoma cell lines, by virtue of episomal maintenance. Moreover, the viral episome provides expression of a transgene in both in vitro and in vivo environments. At present, HVS vectors utilize heterologous promoters such as the IE hCMV promoter. However, this promoter maybe unsuitable for long -term expression in vivo, as promoter silencing has been observed in this and other herpesvirus -based vector systems. Ideal regulatory regions would be functional when the herpesvirus genome is maintained as a latent episome. We have previously shown that gene expression in an HVS -persistently -infected human carcinoma cell line is limited to an adjacent set of genes encoding ORFs 71 -73. These genes are transcribed as a polycistronic mRNA species from a common regulatory region upstream of the ORF 73 gene. In this report, we assess the potential of the ORF 73 regulatory region to provide heterologous gene expression in a wide variety of human cancer cell lines. We demonstrate, utilizing transient transfection assays, that the ORF 73 regulatory region can provide transgene expression in a variety of human carcinoma cell lines, although levels of transgene expression are not as high as achieved under the control of heterologous promoters such as the IE hCMV promoter. Furthermore, incorporation of the minimal ORF 73 regulatory region in a recombinant HVS -based vector provides sustained expression of the green fluorescent protein in both in vitro and in vivo environments. These results suggest that the ORF 73 regulatory region may be suitable for use in HVS -based cancer gene therapy applications.
L
arge DNA viruses, such as herpesviruses, have several advantages as gene delivery vectors. This relates to an ability to package large DNA insertions and establish lifelong latent infections in which the genomic material exists as a stable episome. 1 Herpes simplex virus type 1 ( HSV-1 ), the prototype a-herpesvirus, is being widely developed for gene transfer to the nervous system. 2 -4 HSV-1 -disabled viruses, containing deletions within one or more of the immediate early genes, have been shown to infect and remain latent in neurons with limited toxicity. 5, 6 EpsteinBarr virus (EBV ), a member of the -herpesviruses, is capable of establishing a latent state in dividing cells where the viral episome replicates coordinately with cell division and is inherited by progeny cells. 7, 8 EBV-derived vectors, therefore, have the potential to stably correct human genetic deficiencies in a dividing cell population for a prolonged duration. 9, 10 We and others are currently developing gene delivery vectors based on Herpesvirus saimiri ( HVS ), the prototype -2 herpesvirus of squirrel monkeys. HVS is able to cause a persistent asymptomatic infection in its natural host; however, experimental transfer to other New World primates can result in a range of lymphoproliferative diseases. 11, 12 Deletion of the transforming genes, STP and Tip, is able to completely eliminate the oncogenic potential of the virus, 13 and all our vectors currently under development contain these deletions. For this reason, therefore, the vectors herein should be incapable of transforming any cell type. HVS is capable of infecting a range of human cell lines with high efficiencies, including human T lymphocytes and a variety of carcinoma cell lines. 14 -16 Moreover, the HVS viral genome does not integrate into the cellular genome and persists as a circular nonintegrated episome, which segregates to progeny upon cell division, in both in vitro 17 and in vivo studies. 18 Therefore, HVS -based vectors may have potential for adoptive immunotherapy 19, 20 and gene replacement therapies. 18, 21 However, long -term maintenance of the genome is not in itself sufficient for robust gene therapy. Experience with other systems, such as retroviruses, has shown that integration into the cellular genome may lead to the silencing of transgene expression from commonly used heterologous promoters, such as the IE hCMV. 22 Promoter silencing has also been observed in a number of herpesvirus -based vector systems, 23, 24 including HVS. 21 Alternative promoters to maintain long -term expression in herpesvirus -based vectors are therefore required. Ideal promoters would be functional when the herpesvirus is maintained in the latent state. The restricted but continued transcription of HSV-1 latencyassociated transcripts (LATs ) during latency 25, 26 suggests that the promoter( s ) which mediates this expression could be utilized for long -term expression of heterologous genes. For example, sustained transgene expression within sensory neurons has been achieved using the HSV-1 latencyassociated promoter. 27 -29 We have previously shown that gene expression in a persistently infected HVS human lung carcinoma cell line is limited to an adjacent set of genes encoding ORFs 71 -73. These genes are transcribed as a polycistronic mRNA species from a common regulatory region upstream of the ORF 73 gene. 17 Therefore, in this present study, we have examined the ability of the HVS ORF 73 regulatory region to drive reporter gene expression in a variety of human carcinoma cell lines, in both in vitro and in vivo environments. Our data suggest that the ORF 73 regulatory region may be suitable for long -term transgene expression in HVS -based gene therapy applications.
Materials and methods

Cell culture and transfections
Human carcinoma cells were routinely grown in either RPMI 1640 or Dulbecco's modified Eagle's medium ( Life Technologies, Paisley, UK ) supplemented with 10% (vol / vol ) fetal calf serum (FCS ). All media contained penicillin ( 100 U /mL ) and streptomycin (100 g/ mL ) ( Life Technologies). SW480 cells were stably transduced with HVS-73GFP as previously described. 18 Plasmids used in the transfections were prepared using Qiagen plasmid kits according to the manufacturer's directions (Qiagen, Crawley, UK ). Cells were seeded at 5Â10 5 cells per 35 -mm -diameter Petri dish 24 hours prior to transfection. Transfections were performed using Lipofectamine ( Life Technologies ), as described by the manufacturer, using 2 g of the appropriate DNA.
Plasmid constructs
The 5 0 ORF 73 regulatory region deletion series was produced by a PCR -based method, as previously described. 18 Each fragment was inserted into the eukaryotic chloramphenicol acetyl transferase (CAT ) reporter vector, pCATBasic ( Promega, Southampton, UK ), to derive p73Á1 -6. pSV40-CAT, pCMVCAT, and pRSVCAT, containing the SV40, CMV, and RSV minimal promoters upstream of the CAT reporter gene, were kindly provided by Dr GE Blair ( University of Leeds, Leeds, UK ).
CAT assay
Cell extracts were prepared 48 hours after transfection and incubated with [ 14 C ]chloramphenicol in the presence of acetyl coenzyme A, as described previously. 17 The percentage acetylation of chloramphenicol was quantified using a Biorad FX molecular phosphoimager (Biorad, Herts, UK ).
Construction of the recombinant HVS -73GFP
The plasmid construct, p73GFP, contained the green fluorescent protein GFP and Neomycin genes downstream of the HVS ORF 73 minimal and SV40 promoters, respectively. The 3 0 1.8 kbp of the KpnE fragment of the genome was inserted immediately upstream of the ORF 73 promoter, resulting in a single crossover recombination vector inserting near the junction of the H and L DNA fragments, as described by Grassmann and Fleckenstein. 14 The recombinant HVS -73GFP virus was generated by transfecting 1Â10 6 OMK cells with 2 g of p73-GFP, then infecting with HVS Strain S4 24 hours later at a multiplicity of infection ( MOI ) of 1, and harvesting the virus after 4 days. Green plaques were then isolated and subjected to four rounds of plaque purification. To confirm the correct sitespecific recombination, PCR was performed from a site on the viral genome outside the homologous recombination sequence to a site within the GFP cassette, using the following forward and reverse primers, 5 0 -GTTCCAGTG-AGCAGCAACTGTTAG and 5 0 -CAGCTCCTCGCCCTT-GCTCA, respectively.
Southern blot analysis of the recombinant HVS -73GFP
To confirm the correct recombination event and a single copy of the ORF73 -GFP cassette that had been incorporated in HVS-73GFP, DNA from recombinant and wild type (wt ) viruses was digested with EcoRV and NotI and analysed by Southern blot analysis, as previously described. 18 DNA was hybridized with a 32 P-radiolabelled random -primed probe specific for the GFP coding region, using the Megaprime kit ( Amersham-Pharmacia, Bucks, UK ), as described by the manufacturer.
In vivo analysis
Female athymic Balb /C nude mice ( 8 -10 weeks old; Harland, Oxon, UK ) were maintained and handled in isolators under specific pathogen -free conditions. Mice were randomized into groups of four, and wt SW480 and SW480 HVS -73GFP xenografts were induced by subcutaneous injection of 1Â10 7 cells in 50 L of PBS into the right flank. Human tumor xenografts were allowed to grow to a size of 10Â10 mm, after which mice were sacrificed. The tumor, brain, liver, lung, kidney, heart, spleen, and colon were removed, snap -frozen in liquid nitrogen, and stored at À 808C prior to DNA and protein analysis.
PCR analysis
Tissue samples were homogenized in 10 vol of Trizol (Life Technologies ) and DNA was then extracted, as described by the manufacturer. The HVS ORF 73, mGAPDH, and hGAPDH were PCR -amplified, as previously described. 18 
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Immunoblot analysis
Tumor and tissue samples were homogenized in 5 vol of suspension buffer ( 0.1 M NaCl, 10 mM Tris -HCl, pH 8.0, 1 mM EDTA, and 0.1 mg / mL AEBSF protease inhibitor; Roche, Herts, UK ). Protein extracts were resolved on a 10% SDS polyacrylamide gel, then soaked for 10 minutes in transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol, vol /vol, and 0.1% SDS ). The proteins were transferred to nitrocellulose membranes by electroblotting for 3 hours at 250 mA. After transfer, the membranes were soaked in PBS and blocked by preincubation with 2% (wt/vol) non-fat milk powder for 2 hours at 378C. Membranes were incubated with a 1/ 1000 dilution of the GFP monoclonal antibody (Clontech, Oxford, UK ) or actin antibody (Sigma, Dorset, UK), washed with PBS, and incubated for 1 hour at 378C with a 1 /1000 dilution of antimouse immunoglobulin conjugated with horseradish peroxidase ( Dako, Cambridge, UK ) in blocking buffer.
After five washes with PBS, the nitrocellulose membranes were developed using ECL ( Pierce, Cheshire, UK ), according to the manufacturer's directions.
Photography and immunofluorescence
Excised tumor xenografts were photographed with a yellow Whatman 12 filter (Kodak, Herts, UK ) to eliminate any contaminating blue light. Blue light was used at a wavelength of 488 nm to excite GFP (emission at 507 nm ) and the camera film exposed for 2 minutes. Tumor specimens were embedded in Cryo-M-bed ( Bright Instruments, Huntingdon, UK ), frozen on dry ice, and stored at À 808C. Frozen samples ( 10 m ) were sectioned using a Leica CM3050 cryostat ( Leica, Bucks, UK ) and observed for GFP expression using a Zeiss Axiovert 135TV inverted fluorescence microscope with a Neofluar Â40 oil immersion (Zeiss, Herts, UK ).
Results
The HVS ORF 73 regulatory region is functional in a variety of human carcinoma cell lines
In order to determine whether the HVS ORF 73 regulatory region could provide transgene expression in a variety of human carcinoma cell lines, transient transfection assays were performed. SW480 (colorectal ), MiaPaca (pancreatic ), 
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Herpesvirus saimiri provides long-term transgene expression MS Giles et al MCF -7 (breast ), and A549 ( lung ) human carcinoma cell lines were transfected with a series of ORF 73 regulatory region fragments upstream of the CAT gene, p73Á1-6 ( Fig 1a ) . After 48 hours, cells were harvested and assayed for CAT activity. Protein assays were used to estimate the amount of protein in each extract and transfection efficiency was normalized using a control plasmid pCMVb (Clontech ) expressing b -galactosidase. Results showed that truncated constructs of the ORF 73 regulatory region, specifically Á4 and Á5 encompassing 107,233 -107,972 bp of the published sequence, 30 provided the highest levels of CAT expression in all of the human carcinoma cell lines tested (Fig 1b ) . These results suggest that minimal elements of the ORF 73 regulatory region could provide transgene expression in a variety of human carcinoma cell lines.
The HVS ORF 73 regulatory region provides comparable levels of expression with heterologous promoters in human carcinoma cell lines
To ascertain the amount of transgene expression provided by the ORF 73 regulatory region in human carcinoma cell lines, CAT activity was compared with levels produced by a range of heterologous promoters. These include the IE hCMV, RSV, and SV40 promoters. SW480, MiaPaca, MCF -7, and A549 cell lines were transfected with ORF 73Á5 (minimal ORF 73 regulatory region), SV40CAT, RSVCAT, or CMV-CAT; harvested at 48 hours; and assayed for CAT activity. Protein assays were used to estimate the amount of protein in each extract and transfection efficiency was normalized using a control plasmid expressing b -galactosidase. Results demonstrate that the minimal ORF 73 regulatory region provides fairly consistent levels of transgene expression in all carcinoma cell lines, between 6% and 11% CAT activity ( Fig 2 ) . Although, levels of CAT activity from the SV40 and CMV promoters provided higher levels of expression in most human carcinoma cell lines, lower levels of CAT expression were observed from the SV40 promoter in the breast carcinoma cell line, MCF7. Therefore, these results suggest that minimal elements of the ORF 73 regulatory region may be an alternative regulatory region to provide a 14 b,i: PCR amplification was performed to confirm that the heterologous DNA had recombined in a site -specific manner. DNA was isolated from uninfected ( lane 1 ), wt HVS ( lane 2 ), and HVS -73GFP ( lane 3 ), and PCR amplification performed using a primer downstream from the recombination site and a GFP -specific primer.
ii: Southern blot analysis of HVS -73GFP. DNA was isolated from uninfected ( lane 1 ), HVS -GFP ( lane 2 ), and HVS -73GFP ( lane 3 ), digested with EcoRV and NotI, separated by electrophoresis, transferred to nitrocellulose, and hybridized with a 32 P -radiolabelled random -primed probe specific for the GFP coding region. 
Herpesvirus saimiri provides long-term transgene expression MS Giles et al consistent, albeit lower, level of transgene expression in a variety of human carcinoma cell lines.
HVS -73GFP stably transduces a wide range of human cancer cell lines and provides sustained transgene expression
To determine whether the HVS ORF 73 regulatory region could provide transgene expression when incorporated into the HVS genome, a recombinant HVS expressing the GFP under the control of the minimal ORF 73 regulatory region, HVS -73GFP (Fig 3a) , was generated. This virus was produced by a single crossover event, inserting the minimal ORF 73 regulatory region expressing GFP into a site adjacent to the terminal repeat region at the right -hand end of the genome, as originally described. 14 Deletion analysis has demonstrated that both Á4 and Á5 encompassing 107,233 -107,972 bp of the published sequence 30 provided high levels of CAT expression in all of the human carcinoma cell lines. However, to minimize any possible recombination events within the HVS-73GFP virus, we chose to incorporate the minimal ORF 73 regulatory region that comprises a 329 -bp fragment containing the sequences between 107,233 and 107,562 bp of the published sequence. 30 Upon recombination, the HVS -73GFP virus was plaque -purified and high -titer stocks produced by standard protocols. To confirm that the heterologous DNA had recombined in a site -specific manner, PCR amplification was performed. A PCR fragment was generated using a primer downstream from the recombination site and a GFP -specific primer. A fragment of the correct size was amplified from DNA extracted from HVS-73GFP -infected cells (Fig 3bi ) . Moreover, to confirm the correct recombination event and a single copy of the ORF73 -GFP cassette that had been incorporated in HVS-73GFP, DNA from uninfected, HVS -CMVGFP -, and HVS-73GFP -infected cells were analysed by Southern blot analysis, probing for the GFP transgene (Fig 3bii ) .
To elucidate whether the minimal ORF 73 promoter is functional in human carcinoma cell lines, when incorporated into the HVS genome, HVS -73GFP was used to infect, at an MOI of 1, a variety of human carcinoma cell lines: SW480, HCT 116 (colorectal); MiaPaca, Panc-1 (pancreatic); Oe-19, KYSE 30 (oesophageal ); ST-16, MKN -45 ( gastric ); MCF -7, MDA -MB468 (breast ); and A549 ( lung ). After 48 hours postinfection, GFP expression could be visualized in all cell types using fluorescence microscopy. Figure 4A shows a selection of HVS -73GFP -infected cells lines using fluorescence microscopy; similar results were observed with all the cell lines tested. These results demonstrate that the minimal ORF 73 regulatory region can provide transgene expression in a variety of the human carcinoma cell lines, when incorporated into an HVS -based vector.
In addition, to further study the possibility of the ORF 73 regulatory region providing long -term gene expression, persistently infected HVS -73GFP A549 human carcinoma cell lines were produced and compared with cells infected with HVS -CMVGFP. A total of 1Â10 6 cells were infected with HVS -73GFP or HVS -CMVGFP at an MOI of 1 and grown in the presence of G418 to produce a stably transduced cell line. After 2 weeks, only those cells that had been persistently infected remained viable, with 100% exhibiting the GFP phenotype when analysed by fluorescence microscopy (data not shown). The cells were then serially passaged in the presence of selection and GFP expression was analysed after 6 months postinfection (Fig 4B ) . These results demonstrate that GFP expression is reduced in the HVS-CMVGFP -persistently -infected cell line, indicative of the CMV promoter being silenced as previous observed. In contrast, the majority of the persistently infected HVS -73GFP cells were expressing GFP. This suggests that the 
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The ORF 73 regulatory region provides long -term transgene expression in vivo
To determine whether the ORF 73 regulatory region could provide sustained expression of the transgene in an in vivo environment, human tumor xenografts were induced in nude mice. Wt or HVS-73GFP -persistently -infected SW480 carcinoma cells (10 7 /animal ) were injected into the right flank of Balb /C nude mice and tumor xenografts were allowed to grow to a size of approximately 10Â10 mm. DNA and protein were then extracted from the tumor, brain, heart, lungs, liver, kidney, spleen, and colon of each animal for analysis.
To confirm that HVS -73GFP was maintained during the growth of the human tumor xenograft, as previously observed for other HVS -based vectors, 18 specific amplification of ORF 73 was performed using DNA isolated from the tumor and tissue samples. In addition, as a suitable control, GAPDH DNA was detected in all samples, indicating that sufficient amounts of DNA had been extracted from each tissue. Viral DNA was readily detected in tumor xenografts generated from persistently infected SW480 cells but not in any other host tissues (Fig 5a ) . As expected, viral DNA was not detected in tumor xenografts of wt SW480 cells. These data indicate that the virus can persist within the human carcinoma cell xenografts, as previously observed. 18 To determine whether the ORF 73 regulatory region could provide transgene expression within the tumor xenograft, Western blot analysis was performed on protein extracted from the tumor and tissue samples. GFP expression was readily detectable in the SW480 HVS -73GFP tumor xenograft, but was absent in any other host mouse tissue ( Fig 5b ) . As a control, actin expression was detected in all protein samples, indicating that sufficient amounts of protein had been extracted from each tissue. This result suggests that the ORF 73 regulatory region can provide sustained transgene expression over the course of the 3 -month human carcinoma xenograft experiment.
To further visualize the amount of GFP expression throughout the human carcinoma xenograft, the excised tumors from wt or HVS -73GFP -infected SW480 xenografts were exposed to light emitted at the excitation wavelength for GFP (488 nm ). Widespread GFP fluorescence was observed in SW480 HVS -73GFP tumor xenografts but not in the corresponding wt tumor xenografts ( Fig 6A ) . Furthermore, to confirm that the ORF 73 regulatory region could provide GFP expression throughout the tumor, cross -sections of tumor xenografts were taken and analysed by fluorescence microscopy. GFP expression was observed in over 90% of the cells throughout the persistently infected SW480 tumor xenografts (Fig 6B ) . These results suggest that the HVS episome is segregated efficiently in vivo and that the ORF 73 regulatory region provides sustained expression of a transgene throughout the 3 -month period of tumor xenograft growth.
Discussion
The ability of HVS to enter a persistent infection in human carcinoma cell lines, in which the viral genome is maintained as a stable episome, makes it a candidate for use as a gene delivery vector. However, the long -term maintenance of the viral episome is not in itself sufficient to provide long -term expression of a transgene. We have previously observed a gene -silencing effect using HVS -based vectors, which express GFP under the control of the IE hCMV promoter. For example, a stochastic expression pattern of the IE hCMV promoter was observed during the in vitro differentiation of HVS stably transduced mouse embryonic stem cells. 22 Potential reasons for this lack of expression include the loss of the viral genome upon cell division or the modulation of gene expression through epigenetic effects. A number of previously studies have demonstrated the long -term persistence of the HVS genome within a number of in vitro and in vivo systems. 17, 18, 31 This suggests, therefore, that the genesilencing effect being observed with the HVS -based vector, containing the IE hCMV promoter, is probably due to epigenetic effects.
Sustained therapeutic gene expression remains one of the major challenges to the success of gene therapy. Typically, expression of a transgene undergoes a brief period of expression, only to be followed by reduced levels and finally undetectable expression without loss of the vector. A common mechanism of long -term transcriptional silencing involves methylation of the 5 0 -cytosines present within regulatory elements. 22 DNA methylation displaces histone H1 from nucleosomes and recruits repressive chromosomal proteins, such as histone deacetylases. 32 This deacetylation in nucleosomes, in turn, promotes the condensation of chromatin and thus transcriptional repression. 33 Figure 6 HVS episomes provide sustained transgene expression in vivo. A: The amount of GFP expression was analysed from mice bearing wt SW480 ( i ) and SW480 HVS -73GFP ( ii ) tumors under light emitted at the excitation wavelength for GFP ( 488 nm ). B: To examine the amount of GFP expressed throughout the SW480 HVS -73GFP tumor xenograft, cross -sections were analysed under normal light ( i ) and light emitted at the excitation wavelength for GFP ( ii ).
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The DNA content of HVS and other herpesvirus, including EBV and Kaposi's sarcoma associated herpesvirus ( KSHV ), are deficient in CpG dinucleotides. In contrast, a -and b -herpesvirus dinucleotide frequencies are close to those expected from their mononucleotide composition. 34 CpG sequence in higher eukaryotes is also much lower than would be predicted due to spontaneous deamination of 5 0 -methylcytosine, giving rise to thymidine over an evolutionary timescale. 35 The presence of CpG suppression in -herpesviruses is, therefore, consistent with the heavy methylation of their viral genomes, and may facilitate evasion of the host response and aid in the persistence of the virus -infected cells. 36, 37 Recent analysis has demonstrated that -herpesvirus regulatory regions can be differentially methylated. For example, the KSHV ORF 50 (Rta ) regulatory region is heavily methylated. 38 We and others have shown that constitutive expression of the HVS and KSHV ORF 50 gene products is sufficient to reactivate the latent HVS and KSHV entire lytic replication cycles, respectively. 39, 40 These results, therefore, implicate the methylated repression of the ORF 50 regulatory region in the maintenance of the latent state of the virus. In contrast, analysis of the KSHV ORF 73 regulatory region, which is expressed in latently infected cells, revealed an absence of methylation. This nonmethylated status of the KSHV ORF 73 promoter, therefore, allows the constitutive expression of the latently associated genes and thus the persistence of the viral genome. 38 Similar results have also been observed with differential methylation of EBV virus latency -associated promoters. 37, 41, 42 However, at present, the mechanism by which the latently associated promoters are protected from methylation is unknown. Several possibilities exist: ( a) these promoters may contain specific cis elements, which protect from methylation; and ( b) these promoters become methylated but are then rapidly demethylated by a demethylating enzyme. At present, the methylated status and possibility of methylated inhibitory cis elements within the HVS ORF 73 regulatory region are currently being investigated.
In summary, the differential methylation of -herpesvirus genomes may be advantageous in the development of HVSbased vectors. Firstly, the presence of CpG suppression inherpesviruses is consistent with the heavy methylation of their genomes, and may facilitate evasion of the host response allowing the persistence of a latent infection. Moreover, the latent -associated regulatory regions may be protected from host cell -directed methylation. The unmethylated status of these latent -associated regulatory regions provides a constitutively active promoter to drive sufficient amounts of latent gene expression. Therefore, the HVS ORF 73 regulatory region may be an ideal regulatory region to drive long -term therapeutic gene expression in HVS-based vectors.
